Inovio Pharmaceuticals Inc. Stock Rises 5.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. advanced 5.9% to $1.25 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.

The stock's rise snapped a two-day losing streak.

Inovio Pharmaceuticals Inc. closed 58.0% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.36% to $27.97.

Trading volume totaled 4.6 million, compared to the 50-day average of 3.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 24, 2026 16:33 ET (20:33 GMT)